"My reaction was the same as 25 years ago, when I first saw the preclinical work on rapamycin-eluting stents — a technology from which millions of patients now benefit. I have the same intuition: introduce CD31 onto any human implant, and something similar will happen."
Professor Patrick W. Serruys, MD, Ph.D, FACC, eFESC
Established Professor of Interventional Medicine and Innovation, College of Medicine, Nursing and Health Sciences (CMNHS) University of Galway, Ireland - Senior consultant CORRIB Center for Advanced Imaging & Core Lab Funded Investigator - Emeritus Professor of Medicine, Thoraxcenter, Erasmus University Rotterdam.